ArticleFrontiers in immunology2025

CLEC12A-directed immunocytokine with target cell-restricted IL-15 activity for treatment of acute myeloid leukemia.

Boris Klimovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.